Basal Cell Carcinoma Identification and Treatment of the High-Risk Patient

Author： RANDLE HENRY W.  

Publisher： Elsevier

ISSN： 1076-0512

Source： Dermatologic Surgery, Vol.22, Iss.3, 1996-03, pp. : 255-261

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment options for basal cell carcinoma

By  

Inpharma, Vol. 1, Iss. 1408, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Patient Benefit-Risk Preferences for Targeted Agents in the Treatment of Renal Cell Carcinoma

By Mohamed Ateesha F.  

PharmacoEconomics, Vol. 29, Iss. 11, 2011-11 ,pp. : 977-988

Adis International

Access to resources Recommend Favorite

Mohs Surgery Is Effective for High-Risk Cutaneous Squamous Cell Carcinoma

By PUGLIANO-MAURO MELISSA   GOLDMAN GLENN  

Dermatologic Surgery, Vol. 36, Iss. 10, 2010-10 ,pp. : 1544-1553

Elsevier

Access to resources Recommend Favorite

Basal Cell Carcinoma Rebound After Cessation of Vismodegib in a Nevoid Basal Cell Carcinoma Syndrome Patient

By Wolfe Christopher M.   Green W. Harris   Cognetta Armand B.   Hatfield H. Keith  

Dermatologic Surgery, Vol. 38, Iss. 11, 2012-11 ,pp. : 1863-1866

Elsevier

Access to resources Recommend Favorite

Stroke prevention in the high-risk patient

By Spence J David  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 12, 2007-08 ,pp. : 1851-1859

Informa Healthcare

Access to resources Recommend Favorite